Interim Analysis of Platelet Response in a Prospective Phase 4 Study in Adult Immune Thrombocytopenia (ITP) Subjects after Switching from Eltrombopag (ELT) or Romiplostim (ROMI) to Avatrombopag (AVA)

Background: Three thrombopoietin receptor agonists (TPO-RAs) [eltrombopag, romiplostim, and avatrombopag] are currently approved in the United States (US) and Europe for the treatment of ITP in adult patients. ROMI is administered via injection whereas ELT and AVA are oral medications. Polyvalent ca...

Full description

Saved in:
Bibliographic Details
Published inBlood Vol. 142; no. Supplement 1; p. 2577
Main Authors Tarantino, Michael D., Kolodny, Scott, Zhang, Jessica, Jamieson, Brian, Vredenburg, Michael
Format Journal Article
LanguageEnglish
Published Elsevier Inc 02.11.2023
Online AccessGet full text

Cover

Be the first to leave a comment!
You must be logged in first